SpHincterotomy for Acute Recurrent Pancreatitis

NAActive, not recruitingINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

September 27, 2018

Primary Completion Date

February 28, 2025

Study Completion Date

August 31, 2025

Conditions
PancreatitisPancreas DivisumPancreatitis, AcutePancreatitis IdiopathicPancreas Inflamed
Interventions
PROCEDURE

ERCP with miES

Endoscopic retrograde cholangiopancreatography with minor papilla endoscopic sphincterotomy

PROCEDURE

EUS

Endoscopic ultrasound

Trial Locations (21)

14627

University of Rochester, Rochester

15213

University of Pittsburgh Medical Center, Pittsburgh

22908

University of Virginia, Charlottesville

29407

Medical University of South Carolina, Charleston

30322

Emory University Hospital, Atlanta

43210

The Ohio State University - Wexner Medical Center, Columbus

46202

Indiana University, Indianapolis

55455

University of Minnesota, Minneapolis

60611

Northwestern University, Chicago

64111

Saint Luke's Hospital System, Kansas City

72205

University of Arkansas for Medical Sciences, Little Rock

75203

Methodist Dallas Medical Center, Dallas

90033

Keck Hospital of USC, Los Angeles

90048

Cedars-Sinai, Los Angeles

94143

UCSF Medical Center, San Francisco

97202

Oregon Health and Science University, Portland

98101

Virginia Mason Hospital & Seattle Medical Center, Seattle

06520

Yale School of Medicine, New Haven

02215

Beth Israel Deaconess Medical Center, Boston

03756

Dartmouth-Hitchcock Medical Center, Lebanon

R3A 1R9

Health Sciences Centre, Winnipeg

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Oregon Health and Science University

OTHER

NCT03609944 - SpHincterotomy for Acute Recurrent Pancreatitis | Biotech Hunter | Biotech Hunter